The Aptima HCV Quant Dx assay is an FDA-approved real-time transcription mediated amplification (TMA) test used for both detection and quantification of hepatitis C virus (HCV) RNA in human serum and plasma from HCV-infected individuals. It is intended for use as an aid in the diagnosis of active HCV infection and the management of HCV-infected patients undergoing HCV antiviral drug therapy. It is not approved for use as a screening test for the presense of HCV RNA in blood or blood products.
The quantitative range of this assay is 1.00-8.00 log IU/mL or 10 - 100,000,000 IU mL.
An interpretation of "Not Detected" does not rule out the presence of inhibitors in the patient specimen of HCV RNA concentration below the level of detection of the test. Care should be taken when interpreting any single viral load determination.
Detected, not Quantifiable: HCV RNA detected, but at a level below 10 IU/mL (1.0 log IU/mL). HCV RNA concentration is below the lower limit of quantitation of the assay.
Indeterminate: Error indicated in the generation of the result. Please submit a new specimen for repeat testing if clinically indicated.